Latest Capital Markets News

Haranga Resources has completed its acquisition of the Lincoln Gold Project in California and reported high-grade gold results from its Senegal project, backed by a $14 million capital raise to fast-track exploration and development.

Pivotal Metals Limited has announced a C$2.6 million flow-through share offer targeting Canadian investors, aimed at funding critical minerals exploration in Quebec. The offer complements a concurrent institutional placement, underscoring the company’s aggressive growth strategy amid significant operational risks.

Netlinkz Limited is set to transform into Securelink Networks Limited, consolidating its shares on a 50-for-1 basis to streamline its capital structure and support its expansion into the ASEAN cybersecurity market.

Carnavale Resources has significantly upgraded its Kookynie Gold Project with a new resource estimate and scoping study, underpinning strong economics and a clear path to production. A $3 million placement and a $4.09 million entitlement offer support advancing to a Bankable Feasibility Study in 2026.

Green Critical Minerals advances its Very High Density graphite technology with strong thermal performance validation, production scale-up, and strategic moves into global markets including a planned US listing.

Eclipse Metals has advanced its Greenland rare earths project with expanded drilling and a key licence renewal, while preparing for a NASDAQ dual listing to tap North American investors.

Atomo Diagnostics reported strong commercial momentum in Q1 FY26, highlighted by a key FDA submission for its FebriDx test and a successful capital raise of $1.3 million. The company also showcased promising clinical data for its Active Syphilis test and expanded its HIV Self-Test distribution channels.

Arafura Rare Earths has successfully raised A$475 million through a two-tranche institutional placement, backed by major investors including Hancock Prospecting, to fund the development of its Nolans Project.

Centuria Industrial REIT has secured a landmark 10-year lease with Tesla, delivering a 133% re-leasing spread and deferring redevelopment plans, while pursuing a major data centre expansion in Victoria.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

1414 Degrees has completed key milestones on its SiBox technology, advanced SiBrick storage media towards mass production, and acquired an exclusive licence for innovative silicon nanoparticle tech, backed by a $1.214 million capital raise.

Mont Royal Resources has completed a transformative merger with Commerce Resources, securing A$10 million to advance the Ashram Rare Earths Project, positioning itself as a key player in North America’s critical minerals sector.